A detailed history of Horizons Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Horizons Wealth Management holds 155 shares of PFE stock, worth $3,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155
Previous 155 -0.0%
Holding current value
$3,975
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$25.26 - $29.6 $10,381 - $12,165
-411 Reduced 72.61%
155 $4,000
Q4 2023

Jan 05, 2024

SELL
$26.13 - $33.94 $2,639 - $3,427
-101 Reduced 15.14%
566 $16,000
Q3 2023

Oct 12, 2023

SELL
$32.09 - $37.51 $1,283 - $1,500
-40 Reduced 5.66%
667 $22,000
Q2 2023

Jul 03, 2023

SELL
$36.12 - $41.79 $18,168 - $21,020
-503 Reduced 41.57%
707 $25,000
Q4 2022

Jan 03, 2023

BUY
$41.75 - $54.5 $35,905 - $46,870
860 Added 245.71%
1,210 $62,000
Q2 2022

Aug 19, 2022

BUY
$46.53 - $55.17 $16,285 - $19,309
350 New
350 $17,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Horizons Wealth Management Portfolio

Follow Horizons Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizons Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Horizons Wealth Management with notifications on news.